Deutsche Märkte öffnen in 2 Stunden 9 Minuten

CellaVision AB (publ) (C26.F)

Frankfurt - Frankfurt Verzögerter Preis. Währung in EUR
Zur Watchlist hinzufügen
22,70+0,80 (+3,65%)
Börsenschluss: 08:07AM CEST

CellaVision AB (publ)

Mobilvägen 12
Lund 223 62
Sweden
46 4 64 60 16 00
https://www.cellavision.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter223

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.Founder & Director285kN/A1965
Mr. Simon OstergaardCEO & PresidentN/AN/A1971
Mr. Magnus BlixtChief Financial OfficerN/AN/A1966
Ms. Adele HornCorporate Communications & Investor Relations ManagerN/AN/AN/A
Mr. Peter WilsonVice President of Global MarketingN/AN/A1967
Mr. Urban StrindlovVice President of Global SalesN/AN/A1964
Nina WallanderVice President of Human ResourcesN/AN/A1974
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a web-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, the company offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.

Corporate Governance

CellaVision AB (publ)s ISS Governance QualityScore, Stand 1. Mai 2024, lautet 5. Die grundlegenden Scores sind Audit: 4, Vorstand: 3, Shareholderrechte: 1, Kompensation: 8.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.